SCHEMBL87946

SCHEMBL87946

Oc1cnn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6129089 0.65
SCHEMBL510520 0.65
SCHEMBL27991285 0.63
SCHEMBL595177 0.63
SCHEMBL1930967 0.63
SCHEMBL3842908 0.63
SCHEMBL1187135 0.63 RPS6KA3 (0.42)
SCHEMBL255252 0.62
SCHEMBL2642218 0.62
SCHEMBL166600 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100438205-C Secondary battery SAMSUNG SDI CO LTD (KR) 2008-11-26 CN claimed
EP-0132375-A2 Dihydropyridine anti-ischaemic and antihypertensive agents Pfizer Limited (GB) 1985-01-30 EP claimed
WO-2025029769-A1 SOLID FORMS OF A KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS AND METHOD OF USING THE SAME ELI LILLY AND COMPANY (US) 2025-02-06 WO disclosed
CN-115551923-A Polysulfonamide polymers, positive photosensitive compositions containing them and their use 崔国英 2022-12-30 CN disclosed
WO-2021156792-A1 TARGETED PLASMA PROTEIN DEGRADATION NOVARTIS AG (CH) 2021-08-12 WO disclosed
EP-3856176-A2 INHIBITORS OF VAP-1 Acucela Inc. (US) 2021-08-04 EP disclosed
EP-3154997-B9 AURISTATIN DERIVATIVES AND CONJUGATES THEREOF NOVARTIS AG (CH) 2021-04-14 EP disclosed
EP-3797797-A1 ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST Novartis AG (CH) 2021-03-31 EP disclosed
EP-3578179-B1 PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES ONKURE INC (US) 2020-12-23 EP disclosed
WO-2020236825-A2 MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE NOVARTIS AG (CH) 2020-11-26 WO disclosed
WO-2020069330-A2 INHIBITORS OF VAP-1 ACUCELA INC. (US) 2020-04-02 WO disclosed
WO-2001012150-A1 COSMETIC COMPOSITIONS WITH THERMOCHROMIC COLOR CHANGE SUBSTANCES AND AN AGENT FOR INDUCING A TEMPERATURE CHANGE UNILEVER PLC (GB) 2001-02-22 WO disclosed
WO-2001012149-A1 COSMETIC STRIPS WITH TEMPERATURE DEPENDENT COLOUR CHANGE UNILEVER PLC (GB) 2001-02-22 WO disclosed
CN-1028915-C Silver halide color photographic material FUJI PHOTO FILM CO LTD (JP) 1995-06-14 CN disclosed
WO-1994024111-A1 ARTHROPODICIDAL AND NEMATOCIDAL TRIAZOLES DUNLENA PTY. LIMITED (AU) 1994-10-27 WO disclosed
CN-1055824-A Silver-halide color photoelement FUJI PHOTO FILM CO LTD (JP) 1991-10-30 CN disclosed
US-4732900-A TREATMENT OF SENILITY, ALZHEIMER*S DISEASE BOEHRINGER INGELHEIM KG (DE) 1988-03-22 US disclosed
EP-0180115-A2 1,2,4-Triazolyl carbamates and their acid addition salts, process for their preparation and medicines BOEHRINGER INGELHEIM KG (DE) 1986-05-07 EP disclosed
US-4568677-A CONTROLLED COOLING PFIZER INC. (US) 1986-02-04 US disclosed
EP-0132375-A2 Dihydropyridine anti-ischaemic and antihypertensive agents Pfizer Limited (GB) 1985-01-30 EP disclosed